Publications by authors named "Ostoros Gyula"

Claim this Profile
[
[Modern treatment of lung cancer with immunotherapy].
Krisztina Bogos, Gabriella Temesi, Marianna Pucsok, Lilla Horváth, Gyula Ostoros

Magy Onkol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.
Jeffrey D Bradley, Shunichi Sugawara, Ki Hyeong Lee, Gyula Ostoros, Ahmet Demirkazik

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival of Hungarian Cancer Patients Diagnosed Between 2011 and 2019, Based on the Health Insurance Fund Database.
Zoltán Kiss, Tamás László Berki, Anikó Maráz, Zsolt Horváth, Péter Nagy, Gyula Ostoros

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011-2019 based on a health insurance fund database.
Zoltán Kiss, Anikó Maráz, György Rokszin, Zsolt Horváth, Péter Nagy, Gyula Ostoros

Front Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revising cancer incidence in a Central European country: a Hungarian nationwide study between 2011-2019 based on a health insurance fund database.
Zoltán Kiss, Tamás G Szabó, Csaba Polgár, Zsolt Horváth, Péter Nagy, Gyula Ostoros

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis.
Gyula Ostoros, Robert Hettle, Nefeli Georgoulia, Mehmet Berktas, Pratibha Chander

Expert Rev Anticancer Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
Zsolt Megyesfalvi, Carl M Gay, Helmut Popper, Robert Pirker, Gyula Ostoros

CA Cancer J Clin· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
John V Heymach, David Harpole, Tetsuya Mitsudomi, Janis M Taube, Gabriella Galffy, Gyula Ostoros

N Engl J Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer.
Judit Berta, Anita Rózsás, Zsolt Megyesfalvi, Gyula Ostoros, Balázs Döme

Curr Opin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underlying reasons for post-mortem diagnosed lung cancer cases - A robust retrospective comparative study from Hungary (HULC study).
Zolta N Kiss, Krisztina Bogos, Lilla Tamási, Gyula Ostoros, Veronika Müller

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program.
Anna Kerpel-Fronius, Zsuzsanna Monostori, Gabor Kovacs, Gyula Ostoros, Istvan Horvath

Eur Radiol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary.
Zoltan Kiss, Krisztina Bogos, Lilla Tamási, Gyula Ostoros, Veronika Müller

Pathol Oncol Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Krisztina Bogos, Szilvia Török, Mariann Pucsok, Zsuzsanna Cselko, Ferenc Rényi-Vámos, Gyula Ostoros

Magy Onkol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016.
Gabriella Gálffy, Aladár Vastag, Krisztina Bogos, Zoltán Kiss, Gyula Ostoros

Pathol Oncol Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.
Lilla Tamási, Krisztián Horváth, Zoltán Kiss, Krisztina Bogos, Gyula Ostoros

Pathol Oncol Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.
Krisztina Bogos, Zoltan Kiss, Lilla Tamási, Gyula Ostoros, Veronika Müller

Pathol Oncol Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung Irradiation.
Zsuzsa S Kocsis, Gyöngyi Farkas, András Bajcsay, Márta Kun-Gazda, József Lövey, Gyula Ostoros

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study.
Filippo de Marinis, Konstantin K Laktionov, Artem Poltoratskiy, Inna Egorova, Maximilian Hochmair, Gyula Ostoros

Lung Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Novel approaches to the epidemiology of lung cancer in Hungary].
Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros

Magy Onkol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immunotherapy of lung cancer].
Gyula Ostoros

Magy Onkol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer in Hungary.
Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros

J Thorac Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.
Tanja Cufer, Tudor E Ciuleanu, Peter Berzinec, Gabriela Galffy, Marko Jakopovic, Gyula Ostoros

Oncologist· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.
Taofeek K Owonikoko, Huifeng Niu, Kristiaan Nackaerts, Tibor Csoszi, Gyula Ostoros

J Thorac Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy.
Aron Kristof Ghimessy, Aron Gellert, Erzsebet Schlegl, Balazs Hegedus, Erzsebet Raso, Gyula Ostoros

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary.
Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros

Front Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis